Although we report for the first time that CM from IL-1α-primed MSCs promotes improved outcomes after ischaemic stroke, we do acknowledge that a limitation of this work is the lack of comparison between CM from primed and unprimed MSCs. This evidence concerns the gene IL1A and ischemic stroke.